Middle East Medical Cannabis Market, by Distribution Channel
| Label | Pain Management | Neurological Health Management | Mental Health Management |
|---|---|---|---|
| 2018 | 0.33 USD Mn | 0.23 USD Mn | 0.12 USD Mn |
| 2019 | 1.25 USD Mn | 0.86 USD Mn | 0.45 USD Mn |
| 2020 | 2.49 USD Mn | 1.73 USD Mn | 0.91 USD Mn |
| 2021 | 3.98 USD Mn | 2.81 USD Mn | 1.49 USD Mn |
| 2022 | 5.71 USD Mn | 4.07 USD Mn | 2.19 USD Mn |
| 2023 | 7.79 USD Mn | 5.63 USD Mn | 3.05 USD Mn |
| 2024 | 10.32 USD Mn | 7.54 USD Mn | 4.13 USD Mn |
| 2025 | 13.84 USD Mn | 10.24 USD Mn | 5.67 USD Mn |
| 2026 | 17.11 USD Mn | 12.81 USD Mn | 7.16 USD Mn |
| 2027 | 20.63 USD Mn | 15.65 USD Mn | 8.83 USD Mn |
Data Source: Wantstats Repository
Growth Outlook
- The 2027 portion of the Middle East Medical Cannabis Market, by Application, 2018 market is on a steady long-term growth path. Segment value stands at roughly USD 37 Mn in 2026 and is projected to reach USD 45 Mn by 2027 — a gain of about 22% over the forecast period, translating to a CAGR in the double digits.
- Across all 3 series, Pain Management sits on top as of 2027: 20. 63M USD, or 46% of everything shown here combined.
- What the regional split looks like (2026): Pain Management leads, holding roughly 46% of segment value — the single largest regional share. Neurological Health Management is the second-largest contributor. Mental Health Management make up the remainder, in descending order.
- By 2027, Pain Management alone is expected to reach USD 21 Mn, with Neurological Health Management at USD 16 Mn.
Market Dynamics
Across all 3 series, Pain Management sits on top as of 2027: 20.63M USD, or 46% of everything shown here combined.
Second place: Neurological Health Management, 15.65M USD, trailing Pain Management by 24%.
Pain Management climbs from 330.00K USD (2018) to 20.63M USD (2027), a 6152% gain.
Neurological Health Management: 230.00K USD in 2018 to 15.65M USD by 2027, up 6704%.
Mental Health Management: 120.00K USD to 8.83M USD, 7258% higher by 2027.
Mental Health Management grows fastest of the group, 7258% from 2018 to 2027 — starting smaller doesn't mean staying smaller at this pace.
Combined, all 3 groups add up to 45.11M USD by 2027 — 6534% up from 680.00K USD in 2018.
Making Sense Of 3 Series At Once
This chart compares 3 series side by side, not one trend over time. Read them against each other — the biggest number in the room is not automatically the most important line to follow.
Do not confuse "biggest" with "fastest-growing" — they are frequently different series on a chart like this one, and the gap between them can close faster than the current ranking suggests.
Treat these values as a directional estimate of the Middle East Medical Cannabis market. They are most useful for comparing segments and regions against each other, and for spotting where demand is expected to build fastest.
This is a market research forecast, not an official statistic. Values after the 2018 base year are modeled projections to 2027, based on supply-side and demand-side analysis, and are updated when market conditions change.
Unlock the Full Data
Get This Chart
Access the complete chart and underlying data to support your research, analysis, and business decisions.
Related Charts
View AllMiddle East Medical Cannabis Market, by Application
Middle East Medical Cannabis Market, by Route of Administration
Powering the world's best teams.
From next-gen startups to established enterprises.
Get in Touch
Let's work together
support@wantstats.comSee our work in action
Start your data driven journey with us!
What our clients say
Trusted by forward-thinking businesses
for data-driven intelligence



